These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 39030333

  • 1. Sinensetin Inhibits Angiogenesis in Lung Adenocarcinoma via the miR-374c-5p/VEGF-A/VEGFR-2/AKT Axis.
    Ji T, Ye L, Xi E, Liu Y, Wang X, Wang S.
    Cell Biochem Biophys; 2024 Sep; 82(3):2413-2425. PubMed ID: 39030333
    [Abstract] [Full Text] [Related]

  • 2. Chinese Herbal Compound Xiaoliu Pingyi Recipe Inhibits the Growth of Lung Adenocarcinoma by Regulating the Tumor Vascular Microenvironment.
    Yang FR, Li HL, Hu XW, Fu R, Li XR, Li HJ.
    Integr Cancer Ther; 2024 Sep; 23():15347354241273962. PubMed ID: 39223822
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-204 deregulation in lung adenocarcinoma controls the biological behaviors of endothelial cells potentially by modulating Janus kinase 2-signal transducer and activator of transcription 3 pathway.
    Liu X, Gao X, Zhang W, Zhu T, Bi W, Zhang Y.
    IUBMB Life; 2018 Jan; 70(1):81-91. PubMed ID: 29281186
    [Abstract] [Full Text] [Related]

  • 4. LINC00968 can inhibit the progression of lung adenocarcinoma through the miR-21-5p/SMAD7 signal axis.
    Zhu Y, Bo H, Chen Z, Li J, He D, Xiao M, Xiang L, Jin L, Zhou J, Gong L, Zhou Y, Zhou M, Xiong W, Xing X, Li R, Cao K.
    Aging (Albany NY); 2020 Nov 04; 12(21):21904-21922. PubMed ID: 33147570
    [Abstract] [Full Text] [Related]

  • 5. miR-139-5p Inhibits Lung Adenocarcinoma Cell Proliferation, Migration, and Invasion by Targeting MAD2L1.
    Li J, He X, Wu X, Liu X, Huang Y, Gong Y.
    Comput Math Methods Med; 2020 Nov 04; 2020():2953598. PubMed ID: 33204298
    [Abstract] [Full Text] [Related]

  • 6. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y, Li S, Li J, Wang D, Li Q.
    Cell Physiol Biochem; 2017 Nov 04; 42(4):1431-1446. PubMed ID: 28715819
    [Abstract] [Full Text] [Related]

  • 7. miR-503-5p inhibits colon cancer tumorigenesis, angiogenesis, and lymphangiogenesis by directly downregulating VEGF-A.
    Wei L, Sun C, Zhang Y, Han N, Sun S.
    Gene Ther; 2022 Feb 04; 29(1-2):28-40. PubMed ID: 32533103
    [Abstract] [Full Text] [Related]

  • 8. USF1-induced overexpression of long noncoding RNA WDFY3-AS2 promotes lung adenocarcinoma progression via targeting miR-491-5p/ZNF703 axis.
    Ren P, Hong X, Chang L, Xing L, Zhang H.
    Mol Carcinog; 2020 Aug 04; 59(8):875-885. PubMed ID: 32275336
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-140-3p represses the proliferation, migration, invasion and angiogenesis of lung adenocarcinoma cells via targeting TYMS (thymidylate synthetase).
    Wan S, Liu Z, Chen Y, Mai Z, Jiang M, Di Q, Sun B.
    Bioengineered; 2021 Dec 04; 12(2):11959-11977. PubMed ID: 34818974
    [Abstract] [Full Text] [Related]

  • 10. LncRNA LINC00511 promotes COL1A1-mediated proliferation and metastasis by sponging miR-126-5p/miR-218-5p in lung adenocarcinoma.
    Wang Y, Mei X, Song W, Wang C, Qiu X.
    BMC Pulm Med; 2022 Jul 16; 22(1):272. PubMed ID: 35842617
    [Abstract] [Full Text] [Related]

  • 11. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y, Hu J, Ma J, Feng K, Zhang X, Yang S, Wang W, Zhang J, Zhang Y.
    Eur J Cancer; 2011 Oct 16; 47(15):2353-63. PubMed ID: 21680174
    [Abstract] [Full Text] [Related]

  • 12. LINC01572 promotes the malignant progression of lung adenocarcinoma by modulating p53 mediated by miRNA-338-5p/TTK axis.
    Liu S, Liu X, Yang Q, Zeng C, Hu G, Ren B.
    J Pharm Pharmacol; 2024 Jul 05; 76(7):873-883. PubMed ID: 38698658
    [Abstract] [Full Text] [Related]

  • 13. miR-186-5p promotes cell growth, migration and invasion of lung adenocarcinoma by targeting PTEN.
    Feng H, Zhang Z, Qing X, French SW, Liu D.
    Exp Mol Pathol; 2019 Jun 05; 108():105-113. PubMed ID: 30981721
    [Abstract] [Full Text] [Related]

  • 14. FTO/m6A mediates miR-138-5p maturation and regulates gefitinib resistance of lung adenocarcinoma cells by miR-138-5p/LCN2 axis.
    Ding D, Shang W, Shi K, Ying J, Wang L, Chen Z, Zhang C.
    BMC Cancer; 2024 Oct 12; 24(1):1270. PubMed ID: 39394098
    [Abstract] [Full Text] [Related]

  • 15. The miR-4732-5p/XPR1 axis suppresses the invasion, metastasis, and epithelial-mesenchymal transition of lung adenocarcinoma via the PI3K/Akt/GSK3β/Snail pathway.
    Hu Y, Bai J, Zhou D, Zhang L, Chen X, Chen L, Liu Y, Zhang B, Li H, Yin C.
    Mol Omics; 2022 Jun 13; 18(5):417-429. PubMed ID: 35388387
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-20a-5p suppresses tumor angiogenesis of non-small cell lung cancer through RRM2-mediated PI3K/Akt signaling pathway.
    Han J, Hu J, Sun F, Bian H, Tang B, Fang X.
    Mol Cell Biochem; 2021 Feb 13; 476(2):689-698. PubMed ID: 33125611
    [Abstract] [Full Text] [Related]

  • 17. LncRNA CYTOR knockdown inhibits tumor development via regulating miR-503-5p/PCSK9 in lung adenocarcinoma.
    Zhu Z, Lu J, Tong J, Yin Y, Zhang K.
    Am J Med Sci; 2024 Oct 13; 368(4):382-391. PubMed ID: 38977244
    [Abstract] [Full Text] [Related]

  • 18. HCG18/miR-34a-5p/HMMR axis accelerates the progression of lung adenocarcinoma.
    Li W, Pan T, Jiang W, Zhao H.
    Biomed Pharmacother; 2020 Sep 13; 129():110217. PubMed ID: 32559619
    [Abstract] [Full Text] [Related]

  • 19. miR-30a-5p Regulates Viability, Migration, and Invasion of Lung Adenocarcinoma Cells via Targeting ECT2.
    Chen S, Zhu X, Zheng J, Xu T, Xu Y, Chen F.
    Comput Math Methods Med; 2021 Sep 13; 2021():6241469. PubMed ID: 34306175
    [Abstract] [Full Text] [Related]

  • 20. Tumor-suppressive action of miR-30a-5p in lung adenocarcinoma correlates with ABL2 inhibition and PI3K/AKT pathway inactivation.
    Miao Y, Liu J.
    Clin Transl Oncol; 2024 Feb 13; 26(2):398-413. PubMed ID: 37479901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.